136 related articles for article (PubMed ID: 29034935)
21. The Hedgehog signaling pathway is associated with poor prognosis in breast cancer patients with the CD44+/CD24‑ phenotype.
Zhao H; Tang H; Xiao Q; He M; Zhao L; Fu Y; Wu H; Yu Z; Jiang Q; Yan Y; Jin F; Wei M
Mol Med Rep; 2016 Dec; 14(6):5261-5270. PubMed ID: 27779682
[TBL] [Abstract][Full Text] [Related]
22. Hedgehog signaling pathway as a therapeutic target in various types of cancer.
Onishi H; Katano M
Cancer Sci; 2011 Oct; 102(10):1756-60. PubMed ID: 21679342
[TBL] [Abstract][Full Text] [Related]
23. Targeting the Hedgehog signaling pathway in cancer: beyond Smoothened.
Gonnissen A; Isebaert S; Haustermans K
Oncotarget; 2015 Jun; 6(16):13899-913. PubMed ID: 26053182
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of Ciliogenesis Promotes Hedgehog Signaling, Tumorigenesis, and Metastasis in Breast Cancer.
Hassounah NB; Nunez M; Fordyce C; Roe D; Nagle R; Bunch T; McDermott KM
Mol Cancer Res; 2017 Oct; 15(10):1421-1430. PubMed ID: 28611083
[TBL] [Abstract][Full Text] [Related]
25. Anti-cell growth and anti-cancer stem cell activities of the non-canonical hedgehog inhibitor GANT61 in triple-negative breast cancer cells.
Koike Y; Ohta Y; Saitoh W; Yamashita T; Kanomata N; Moriya T; Kurebayashi J
Breast Cancer; 2017 Sep; 24(5):683-693. PubMed ID: 28144905
[TBL] [Abstract][Full Text] [Related]
26. The role of hedgehog signaling in gastric cancer: molecular mechanisms, clinical potential, and perspective.
Xu Y; Song S; Wang Z; Ajani JA
Cell Commun Signal; 2019 Nov; 17(1):157. PubMed ID: 31775795
[TBL] [Abstract][Full Text] [Related]
27. The intrahepatic signalling niche of hedgehog is defined by primary cilia positive cells during chronic liver injury.
Grzelak CA; Martelotto LG; Sigglekow ND; Patkunanathan B; Ajami K; Calabro SR; Dwyer BJ; Tirnitz-Parker JE; Watkins DN; Warner FJ; Shackel NA; McCaughan GW
J Hepatol; 2014 Jan; 60(1):143-51. PubMed ID: 23978713
[TBL] [Abstract][Full Text] [Related]
28. Triple-negative breast cancer: current state of the art.
Rastelli F; Biancanelli S; Falzetta A; Martignetti A; Casi C; Bascioni R; Giustini L; Crispino S
Tumori; 2010; 96(6):875-88. PubMed ID: 21388048
[TBL] [Abstract][Full Text] [Related]
29. Targeting Hedgehog signaling and understanding refractory response to treatment with Hedgehog pathway inhibitors.
Queiroz KC; Spek CA; Peppelenbosch MP
Drug Resist Updat; 2012 Aug; 15(4):211-22. PubMed ID: 22910179
[TBL] [Abstract][Full Text] [Related]
30. The role of the Hedgehog signaling pathway in cancer: A comprehensive review.
Skoda AM; Simovic D; Karin V; Kardum V; Vranic S; Serman L
Bosn J Basic Med Sci; 2018 Feb; 18(1):8-20. PubMed ID: 29274272
[TBL] [Abstract][Full Text] [Related]
31. Hedgehog signal pathway is activated in ovarian carcinomas, correlating with cell proliferation: it's inhibition leads to growth suppression and apoptosis.
Chen X; Horiuchi A; Kikuchi N; Osada R; Yoshida J; Shiozawa T; Konishi I
Cancer Sci; 2007 Jan; 98(1):68-76. PubMed ID: 17083567
[TBL] [Abstract][Full Text] [Related]
32. The Hedgehog signaling pathway plays an essential role in maintaining the CD44+CD24-/low subpopulation and the side population of breast cancer cells.
Tanaka H; Nakamura M; Kameda C; Kubo M; Sato N; Kuroki S; Tanaka M; Katano M
Anticancer Res; 2009 Jun; 29(6):2147-57. PubMed ID: 19528475
[TBL] [Abstract][Full Text] [Related]
33. Paracrine Hedgehog signaling in cancer.
Theunissen JW; de Sauvage FJ
Cancer Res; 2009 Aug; 69(15):6007-10. PubMed ID: 19638582
[TBL] [Abstract][Full Text] [Related]
34. Role of hedgehog signaling in ovarian cancer.
Bhattacharya R; Kwon J; Ali B; Wang E; Patra S; Shridhar V; Mukherjee P
Clin Cancer Res; 2008 Dec; 14(23):7659-66. PubMed ID: 19047091
[TBL] [Abstract][Full Text] [Related]
35. Hedgehog beyond medulloblastoma and basal cell carcinoma.
Teglund S; Toftgård R
Biochim Biophys Acta; 2010 Apr; 1805(2):181-208. PubMed ID: 20085802
[TBL] [Abstract][Full Text] [Related]
36. Mesenchymal Cells Support the Oncogenicity and Therapeutic Response of the Hedgehog Pathway in Triple-Negative Breast Cancer.
Reyes-Ramos AM; Ramos-Cruz KP; Rodríguez-Merced NJ; Martínez-Montemayor MM; Franqui-Ríos ND; Ríos-Grant JP; Flores A; Maldonado-Martínez G; Torres-García W; Domenech M
Cancers (Basel); 2019 Oct; 11(10):. PubMed ID: 31658643
[TBL] [Abstract][Full Text] [Related]
37. HH/GLI signalling as a new therapeutic target for patients with oral squamous cell carcinoma.
Yan M; Wang L; Zuo H; Zhang Z; Chen W; Mao L; Zhang P
Oral Oncol; 2011 Jun; 47(6):504-9. PubMed ID: 21536478
[TBL] [Abstract][Full Text] [Related]
38. Hedgehog inhibitor sonidegib potentiates
Spetz J; Langen B; Rudqvist N; Parris TZ; Helou K; Nilsson O; Forssell-Aronsson E
BMC Cancer; 2017 Aug; 17(1):528. PubMed ID: 28789624
[TBL] [Abstract][Full Text] [Related]
39. Human breast cancer-associated fibroblasts (CAFs) show caveolin-1 downregulation and RB tumor suppressor functional inactivation: Implications for the response to hormonal therapy.
Mercier I; Casimiro MC; Wang C; Rosenberg AL; Quong J; Minkeu A; Allen KG; Danilo C; Sotgia F; Bonuccelli G; Jasmin JF; Xu H; Bosco E; Aronow B; Witkiewicz A; Pestell RG; Knudsen ES; Lisanti MP
Cancer Biol Ther; 2008 Aug; 7(8):1212-25. PubMed ID: 18458534
[TBL] [Abstract][Full Text] [Related]
40. The Hedgehog signalling pathway in breast development, carcinogenesis and cancer therapy.
Hui M; Cazet A; Nair R; Watkins DN; O'Toole SA; Swarbrick A
Breast Cancer Res; 2013 Mar; 15(2):203. PubMed ID: 23547970
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
